Pricing Log in Create free account

Neumora Therapeutics, Inc. (NMRA) vs Seer, Inc. (SEER)

Neumora Therapeutics, Inc. and Seer, Inc. are both Biotechnology companies. Neumora Therapeutics, Inc. and Seer, Inc. are of similar size ($91.5M and $90.3M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 14 metrics below, Seer, Inc. leads on 9 and Neumora Therapeutics, Inc. on 5.

Valuation

Metric NMRA SEER Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.36 9.40
P/B 2.04 0.40 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.97 0.66
EV/Sales n/m (4.39) 9.02
Earnings yield (251.02%) (74.39%) (32.88%)
Free cash flow yield (198.74%) (48.61%) (23.13%)

Profitability

Metric NMRA SEER Biotechnology median
Gross margin 0.00% 47.70% 68.51%
Operating margin 0.00% (498.19%) 0.00%
Net margin 0.00% (478.05%) 0.00%
Free cash flow margin 0.00% (309.34%) 0.00%
Return on equity (187.11%) (26.45%) (51.96%)
Return on assets (121.89%) (23.47%) (46.06%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric NMRA SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.76%
EPS growth (last fiscal year) 5.23% 7.91% 29.88%
Revenue growth, 5-year CAGR — 90.78% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA SEER Biotechnology median
Debt to equity 1.19 0.00 0.00
Current ratio 4.50 14.74 4.97
Net debt to EBITDA 0.53 2.63 1.01

Dividend

Metric NMRA SEER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NMRA SEER Biotechnology median
Market cap 91.51m 90.25m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack